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Abstract
Despite the clinical ubiquity of anesthesia, the molecular basis of anesthetic action is poorly understood. Amongst the many
molecular targets proposed to contribute to anesthetic effects, the voltage gated sodium channels (VGSCs) should also be
considered relevant, as they have been shown to be sensitive to all general anesthetics tested thus far. However, binding
sites for VGSCs have not been identified. Moreover, the mechanism of inhibition is still largely unknown. The recently
reported atomic structures of several members of the bacterial VGSC family offer the opportunity to shed light on the
mechanism of action of anesthetics on these important ion channels. To this end, we have performed a molecular dynamics
‘‘flooding’’ simulation on a membrane-bound structural model of the archetypal bacterial VGSC, NaChBac in a closed pore
conformation. This computation allowed us to identify binding sites and access pathways for the commonly used volatile
general anesthetic, isoflurane. Three sites have been characterized with binding affinities in a physiologically relevant range.
Interestingly, one of the most favorable sites is in the pore of the channel, suggesting that the binding sites of local and
general anesthetics may overlap. Surprisingly, even though the activation gate of the channel is closed, and therefore the
pore and the aqueous compartment at the intracellular side are disconnected, we observe binding of isoflurane in the
central cavity. Several sampled association and dissociation events in the central cavity provide consistent support to the
hypothesis that the ‘‘fenestrations’’ present in the membrane-embedded region of the channel act as the long-
hypothesized hydrophobic drug access pathway.
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Introduction
Voltage gated sodium channels (VGSCs), which mediate the
upstroke of the action potential in most excitable tissues, are key
targets of anesthetics. The binding site and molecular mechanism
of action for local anesthetics have been well characterized in the
last few decades, while the role of VGSCs in general anesthetic
action is less well understood and both mechanisms continue to be
studied. Thus far, the VGSC binding sites for general anesthetics
have not been identified. Identifying binding sites and access
pathways for volatile general anesthetics is key to understanding
their mechanism of action and to designing new drugs.
Sodium channels can be inhibited by a number of compounds,
including toxins, quaternary ammonium compounds and local
anesthetics [1]. When the pore is open, local anesthetics can enter
from the intracellular side blocking conduction of ions. More
recent work shows that general anesthetics also inhibit sodium
channels, possibly through pore-blocking mechanisms [2–7].
Anesthetic block by both local and general anesthetics is preserved
in the archetypal bacterial voltage-gated channel NaChBac [4,8].
Early observations [9] pointed to a local anesthetic binding site
inside the channel, and indeed, in Nav 1.2, the binding site
suggested by mutagenesis is in the central cavity [10]. The effect of
local anesthetics on NaChBac is consistent with a cavity-binding
site, although the precise binding pocket is probably not the same
as in Nav 1.2 [8]. It is thus conceivable that local and inhaled
general anesthetic sites in the channel cavity in NaChBac overlap.
The classical studies of charged local anesthetics and their analogs
showed that blocking and unblocking seemed to require open
channels. This led to the description of the ‘‘hydrophilic pathway’’
for drug access. However, additional experiments showed that
hydrophobic local anesthetics could bind and unbind even when
channels are closed [11–13]. This finding suggested an additional
‘‘hydrophobic pathway’’ that circumvents the closed gate. However, no
structural correlate for this pathway has yet been conclusively
identified.
Although large mammalian VGSCs have remained resistant to
structural characterization, the discovery of the smaller bacterial
VGSCs has provided a tool to characterize the structural features
of these important channels [14,15]. In general, the major
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structural domains resemble those found in the crystal structures of
voltage-gated K+ channels (Figure 1A). Transmembrane domains
S1–S4 form the voltage-sensing domain (VSD), which is connected
to the pore domain through the S4–S5 linker. The pore domain,
formed by domains S5 and S6 includes the pore-loops (P-loops),
which form the ion selectivity filter and may also constitute an
inactivation gate [16,17]. On the intracellular side, four S6-
domains form the bundle crossing that constitutes the activation
gate [18–20]. The S4–S5 linkers form a cuff around the bundle
crossing, such that in the presence of a depolarizing stimulus,
conformational changes in the VSD widen this cuff, allowing the
bundle crossing to open to permit conduction.
A striking feature of the bacterial VGSC crystallized thus far is
the presence of the so-called fenestrations [21–23]. These fenestra-
tions provide a hydrophobic tunnel through the lipid-embedded
portion of the channel to the central cavity, where the consensus
local anesthetic site is located. In X-ray crystal structures, lipid tails
occupy the fenestrations. These fenestrations may provide the
hydrophobic drug access pathway that has been postulated for
sodium channels since the 1970s [12,13,24].
The available atomic structure of a bacterial VGSC offers the first
opportunity to address some of the most fundamental questions about
the mechanism of volatile anesthetic action on VGSCs, namely what
are the likely structural determinants of general anesthetic effects on
VGSCs and could the fenestrations really provide access to the central
cavity for small hydrophobic drugs? To investigate these questions, we
present the results of a molecular dynamics (MD) simulation study of
the bacterial VGSC NaChBac embedded in a lipid bilayer in presence
of the inhaled general anesthetic isoflurane. Our unbiased ‘‘flooding’’
technique [25] is a way to flexibly dock isoflurane molecules to high
affinity sites of the membrane-bound protein, as well as to thereby
suggest energetically favorable drug binding pathways.
Results
Identification of isoflurane binding sites
To identify putative isoflurane binding sites, we performed MD
‘‘flooding’’ simulations [25] on a structural model of NaChBac
[26] inserted in a hydrated lipid bilayer (Figure 1, A and B, Movie
S1). We considered a system comprising the membrane-bound
channel along with a large number of drug molecules, initially
located in the aqueous phase (Figure 1B). As expected from the
Meyer-Overton rule, we observed almost complete partitioning
into the membrane within the first 100 ns of MD simulation
(Figure S1). In the subsequent MD trajectory, we observed binding
to several hydrophobic pockets on the protein surface with at most
a single isoflurane molecule in the aqueous phase. Importantly, the
conformation of NaChBac was not significantly affected on the
time-scale of our MD simulation by the binding of isoflurane
molecules, as inferred from the RMSD of the channel along the
MD trajectory (Figure S2). The potentially large number of
binding sites poses a challenge in identifying which of these may be
pharmacologically relevant. To overcome this challenge we
applied a two-fold strategy in which we first explored all the
possible binding modes of isoflurane, and then used an established
data-mining approach [27] to extract distinct configurations from
our large data-set of molecular configurations. Specifically, we
perform a cluster analysis on the positions of the centers of mass of
the whole ensemble of isoflurane molecules and ranked the
clustering solutions according to their local density. The rationale
for this choice is to prioritize those regions that show continuous
occupancy, which would suggest tighter binding of the drug
molecule. This analysis revealed three major binding regions
(Figure 1C): 1) a region near the selectivity filter, termed the
extracellular site, 2) a region near the S4–S5 linker, termed the
linker site, and 3) a region within the cavity, termed the cavity site.
Due to the protein’s four-fold symmetry, a functional channel
has four equivalent copies of each of the three putative binding
sites. To investigate whether the three putative sites are occupied
symmetrically in the tetramer, and to determine which amino
acids line each site, we analyzed the interactions between
isoflurane and all the residues within the sites in each subunit.
In particular, we monitored the contacts between any atom of the
drug molecule and any atom of a given amino acid for each
instantaneous configuration after isoflurane partitioning has
reached equilibrium. Residues were classified as non-interacting,
‘‘possibly’’ interacting, and ‘‘likely’’ interacting according to the
number of configurations in which the contact was detected. For
the extracellular site, all amino acids in all four subunits are in
contact with the drug. In the cavity site as well as through the
fenestrations, most residues are possibly or likely interacting in all
four subunits. Intriguingly, the linker site is asymmetrically
occupied in two adjacent sites.
Characterization of isoflurane sites
We used the clustering data and proximity time analyses, in
combination with analysis of hydrogen-bonding-like interactions
and mobility of the drug molecule in the sites, to structurally
characterize the sites and elucidate the key determinants of
binding. Furthermore, to assess the pharmacological relevance of
these sites, we estimated the binding free energy of isoflurane for
each site using well-established FEP methods [28], allowing us to
rank the relative free energy at each site. We also estimated
binding affinities (Kd) and found that they were within a
reasonable physiological range (see Methods) [29].
Extracellular site. The extracellular site sits at the inter-
subunit interface between the P-loops (Figure 2, A and B). The
majority of drug-sidechain interactions in this site are non-polar
(E172, L179, L182, W193, A194, M198, R199, F202), however a
hydrogen-bond-like interaction exists between fluorine atoms of
isoflurane and Gln 186. Isoflurane enters all four equivalent
cavities within a few nanoseconds and remains there for the
Author Summary
The molecular mechanisms mediating the pharmacologi-
cally induced state of general anesthesia are, in general,
poorly understood. Modulation of voltage gated sodium
channels is thought to play a major role in anesthesia, as
several members of this class of channels show a
significant response to general anesthetics. However, the
detailed mechanism of inhibition or potentiation of these
channels is completely unknown. Recently, the structures
of several members of the bacterial family became
available, thereby offering the opportunity to shed light
on some of these issues. We have performed molecular
dynamics simulations on one of these bacterial voltage
gated sodium channels, NaChBac, to identify binding sites
and access pathways for the volatile general anesthetic
isoflurane. We found that isoflurane, at physiologically
relevant concentrations, binds the channel at three distinct
sites. One site is in the pore of the channel, suggesting that
isoflurane may hinder the permeant sodium ions. Surpris-
ingly, we found that this binding site is accessible to the
drug even when the pore and the aqueous compartment
at the intracellular side are disconnected. In our simula-
tions, the ‘‘fenestrations’’ present in the membrane-
embedded region of the channel act as the long-
hypothesized hydrophobic drug access pathway.
Binding of Isoflurane to NaChBac
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duration of the simulation (Table S1). The estimated binding free
energy (DGbinding) for this site is 24.260.8 kcal/mol. Consistent
with the notion of a tight-binding interaction, rotational and
translational diffusion in this site are restricted compared to
aqueous solution (Table S2). Additionally, the corresponding
diffusion constants are the smallest among all sites (Table S2).
Linker site. The linker site is located at the ‘‘corner’’ formed
by the N-terminus of one linker and the C-terminus of the
adjacent linker (Figure 2, B and C). This site is the most dynamic
and heterogeneous of the three sites, with variable occupancy and
exchange of isoflurane molecules. Unlike the other sites, this site is
asymmetrically occupied, with the a–d and c–d sites (Figure 2,
legend) continuously occupied, while the other two equivalent sites
are not occupied for any significant length of time over the course
of the simulation (Table S1). Either one or two isoflurane
molecules occupy the a–d site, while the c–d site is occupied by
only one molecule. Also for this site, the majority of drug-protein
interactions are non-polar (Leu133, Ala136 and Ile147) but a
hydrogen–bonding–like interaction exists with Asn 225. The
estimated DGbinding for this site is 23.7620.4 kcal/mol for the
first isoflurane molecule and 22.6620.9 for the second molecule,
given the first one is already bound. In contrast to the extracellular
binding site, only translational diffusion is significantly slower
compared to aqueous solution, suggesting that isoflurane retains a
significant degree of conformational flexibility inside the pocket.
Pore site. Though the activation-gate is closed, we find that
the central cavity is occupied by up to five isoflurane molecules at
once (Figure 2, D and E, Figure 3, A and B). All interactions in the
pore are hydrophobic and isoflurane molecules associate with a
number of residues. Importantly, we observed a stable interaction
with residues known to play a role in local anesthetic action in
mammalian sodium channels (F1764 and Y1771 in Nav1.2),
which are partially conserved in NaChBac (T220 and F227) [8,10]
(Table S1). Despite the fact that we observe exchange between the
central cavity and the hydrophobic section of the lipid bilayer, the
cavity is almost always occupied by at least one drug molecule
(Figure 3 B). Therefore we expect the affinity for this site to be
comparable to those for the other sites.
Given that isoflurane molecules in the central cavity are in
direct contact with water, we were surprised that diffusion
translational constant is comparable to those observed in the
other two binding sites.
Fenestrations. Our homology model of NaChBac preserves
the fenestrations found in the NavAb crystal structure [21,26],
which provide a hydrophobic tunnel from the protein surface to
the central cavity. We anticipated isoflurane occupation of
hydrophobic pockets on the NaChBac protein surface, but were
unsure whether isoflurane molecules would be able to fully
traverse the fenestrations to displace bound waters and access the
pore. In the flooding simulation, the S6 gate was closed, and there
was no hydrophilic pathway for the drug molecules to the central
cavity. Nevertheless, several isoflurane molecules were able to
reach the pore through the fenestrations, displacing water
molecules that left the central cavity through the selectivity filter.
Interestingly, each isoflurane molecule is able to displace
approximately six water molecules (Figure 3A). Thus, in presence
of a drug molecule, two solvation shells of water cannot surround a
permeant sodium ion. An intriguing hypothesis raised by this
observation is that inhibition may result from desolvation of the
central cavity rather than steric hindrance, therefore a correlation
between molecular volume of the drug and potency should be
expected for this site. We found that isoflurane can both enter and
exit the pore via fenestrations (Figure 4, Movie S2) and that all
four fenestrations had both exchange and occupation by isoflurane
(Table S1). This observation strongly suggests that fenestrations
can act as a hydrophobic access pathway to the central cavity for
small hydrophobic drugs such as isoflurane. However, it is still
unclear if larger hydrophobic drugs, including other general
anesthetics like sevoflurane and propofol, could traverse the same
fenestration pathway. Crystal structures of NavBacs have so far
shown that the fenestrations are occupied by the alkyl moiety of
lipid molecules. Our simulations confirm that in the absence of
isoflurane, each fenestration is occupied by the alkyl moiety of a
lipid molecule; but in the presence of isoflurane, the lipid tails are
displaced allowing isoflurane to enter the central cavity.
Discussion
Using an unbiased sampling of cavities within the bacterial
channel NaChBac, we identified three putative binding sites for
isoflurane. These binding sites are located at the extracellular side
of the channel near the selectivity filter, at the linker between S4
and S5, and in the central cavity. Though the estimated binding
free energies indicate high affinity, isoflurane molecules explore
several orientations within each binding site. Due to the flexible
nature of the Asn and Gln side-chains, isoflurane is able to form
stable interactions with the protein at the extracellular and linker
sites. Surprisingly, despite the fact that the pore is not accessible
from the intracellular side, isoflurane molecules were able to
reach the central cavity through the fenestrations. This observa-
tion suggests that the fenestrations could be the anesthetic
hydrophobic pathways proposed more than three decades ago
[12,13,24].
Possible mechanisms of anesthetic action
All three identified sites are in regions of the protein that are
predicted by mutagenesis to be critical to gating and conduction,
and we hypothesize that some or all of them will play a role in
inhibition of NaChBac by isoflurane. Since the time-scales
involved in the molecular events relevant for gating are beyond
normal MD simulation time-scales, we cannot directly probe the
effect of drug interactions on protein conformation. However,
based on knowledge of the mechanisms of gating, conduction, and
inhibition by local anesthetics, we postulate possible mechanisms
of drug action involving the binding sites suggested by our
simulations. Isoflurane binding to the extracellular site positioned
in the P-loops could affect the conformation of the selectivity filter,
leading to inactivation through filter collapse [16,17] and
consequent reduction in peak current. Isoflurane binding to the
linker site, which sits between the cuff formed by the S4–S5 linkers
and the S6 bundle crossing, could affect the conformation or the
coupling between the cuff and the bundle crossing to halt gating
[30–32]. Finally, isoflurane in the pore site could simply occlude
the pore through classical local anesthetic mechanisms [1], which
has also been recently proposed as an inhibition mechanism of the
GLIC channel by the same anesthetic [33]; this open channel
Figure 1. Simulation setup and isoflurane binding sites. (A) Structural domains of NaChBac showing the VSD (purple), the S4–S5 linkers (red)
and the pore domain (blue/green) with the S6 helices highlighted in green. (B) Isoflurane flooding simulation system initial setup showing the
NaChBac protein (orange) in the POPC bilayer (white) with isoflurane molecules in the aqueous phase. (C) The three binding sites identified by
clustering analysis: extracellular site (red), linker site (yellow) and cavity site (purple/green).
doi:10.1371/journal.pcbi.1003090.g001
Binding of Isoflurane to NaChBac
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block could be either purely steric or enhanced by the desolvation
of the pore.
Though theories of anesthetic action focus primarily on
anesthetic-protein interactions, the role of lipids cannot be
discounted as partitioning into the bilayer changes lipid properties
[34,35]. For the structurally unrelated channel gramicidin the
effect of halothane on channel’s function has been shown to be
dependent on lipid composition [36]. Channel interactions with
Figure 2. Isoflurane binding sites. Extracellular (A and B) and linker site (C and D): residues interacting with isoflurane are highlighted in the insets
B and D. For clarity, alternating subunits are shown in cyan/pink and labeled a through d. (E and F) Side and top views of isoflurane molecules
occupying the cavity site and fenestrations.
doi:10.1371/journal.pcbi.1003090.g002
Binding of Isoflurane to NaChBac
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Figure 3. Isoflurane displacement of cavity water molecules. (A) Absolute number of water molecules (red) and isoflurane molecules (blue)
within the cavity as a function of time. (B) Number of cavity waters as a function of the number of bound isoflurane molecules. Note that each
isoflurane molecule displaces approximately 6 waters.
doi:10.1371/journal.pcbi.1003090.g003
Binding of Isoflurane to NaChBac
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lipids are important in regulating voltage sensing, gating and
voltage-sensor-pore coupling [37–39] in voltage-gated ion chan-
nels. NaChBac’s lipid sensitivity [40] suggests that appropriate
lipid interactions regulate NaChBac function, and thus anesthetic
partitioning could indirectly regulate the channel via disruption of
lipid interactions. However, this simulation study is not designed to
give realistic insights into lipid-anesthetic regulation for two
reasons: first, because the lipid composition is not representative of
a realistic bacterial or mammalian membrane and second, because
the time-scale of the simulation is too short to observe lipid effects
on channel structure and dynamics.
Testable hypotheses
This simulation of isoflurane binding sites and access pathways
offers a number of experimentally testable hypotheses. While
simulation shows that it is thermodynamically favorable for
isoflurane to occupy these sites, it is possible that isoflurane
occupation may have little or no physiological function. The
functional relevance of each site can be ascertained by mutating
each site individually to remove key determinants of isoflurane
binding and evaluating whether NaChBac retains isoflurane
sensitivity through electrophysiological assays [4]. The putative
hydrogen bonding partners in the extracellular and linker sites (Gln
186, Asn 225 respectively) are particularly good candidates for
mutagenesis, as point mutations changing the polar character of the
residue are likely to cause a large change in binding affinity at these
sites. Mutation of the cavity is likely to prove difficult, as isoflurane is
highly mobile and interactions are nonspecific – the cavity site may
be better probed through classical use-dependence and trapping
assays [1]. Most intriguingly, the relevance of the fenestrations as a
drug access pathway could also be probed through mutations that
occlude the fenestration pore at the extracellular side.
Comparison to other anesthetic-channel simulations
Though no one has previously performed molecular dynamics
simulation on voltage-gated sodium channels to identify anesthetic
sites, numerous simulations have been done on ligand-gated ion
channels (LGICs) due to the availability of the structures of
bacterial homologues [41–43]. Simulation of anesthetic sites in
LGICs, primarily based on the ELIC structure, have identified
predominantly intersubunit sites, as well as a few intrasubunit sites
[33,44–50]. These sites are also the most common types identified
experimentally [51,52], though pore sites have also been found
[45,52–55]. In fact, all isoflurane sites identified in NaChBac are
intersubunit sites, with the pore site also being intersubunit.
Importantly, the observation that binding occurs at the inter-
subunit regions in both voltage- and ligand-gated channels
suggests that anesthetics may impair the cooperative conforma-
tional transitions that have been shown to be crucial for the
function of ion channels.
Conclusions
Experimental verification of the aforementioned predictions will
prove crucial to deepen our understanding of sodium channels
modulation by anesthetics and will likely prompt further computational
investigations. Indeed, despite providing a relatively accurate and
detailed description of drug-channel binding events, our computational
model is characterized by several limitations: (i) simulations were
performed on a homology-based model of NaChBac; (ii) only one of
the metastable structural conformations of the channel was probed for
drug binding; (iii) lipid dependence of drug action was not addressed.
Though the high degree of sequence identity with NavAb gives us
confidence on the overall architecture of NaChBac, inaccuracies in the
structure of the binding sites or major reorganizations of these pockets
along the activation pathway can both potentially affect our results.
Increased availability of experimental structures [22,56] and a detailed
characterization of the conformational transitions entailed by the
activation/deactivation cycle [57] will allow us to address these issues in
future computational studies, as well as being able to begin to work
with eukaryotic channels [58,59].
Methods
MD simulations
Simulations were initialized using the theoretical model of
NaChBac in a closed conformation obtained previously [26]. This
Figure 4. Fenestrations as the hydrophobic access pathway. A and B show two views of an isoflurane molecule diffusing in (A) and out (B) of
the central cavity through two adjacent fenestrations. Cavity and fenestrations are shown as grey surfaces.
doi:10.1371/journal.pcbi.1003090.g004
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homology model was built on the basis of the X-ray crystal
structure of NavAb (PDB ID: 3RVY), which was crystallized in a
closed-pore conformation with all four voltage-sensing domains
partially activated [57].
The model for the closed NaChBac channel, embedded in a
fully hydrated lipid bilayer, was equilibrated by MD simulation.
Specifically, the membrane is comprised of 1-palmytoyl-2-oleoyl-
sn-glycero-3-phosphatidylcholine (POPC) lipid molecules. Isoflur-
ane molecules were initially placed in the aqueous phase with
random positions and orientation. The membrane protein
complex contained a total of ,120,000 atoms, including
NaChBac, 434 lipid molecules, 25310 water molecules, 236 ions
in solution and 145 isoflurane molecules. The resulting initial
aqueous concentration of isoflurane is 300 mM; the equilibrium
aqueous concentration 0.9 mM. Two Na+ ions were initially
placed in the channel selectivity filter, in agreement with a
previous computational study of NavAb showing double occu-
pancy of the filter by Na+ ions [60]. All charged amino acids were
protonated using their respective pKas and the assumption that
the solution was at pH 7. MD trajectories were collected for
0.5 ms.
MD simulation used the CHARMM22-CMAP force field with
torsional cross-terms for the protein and CHARMM27 for the
phospholipids [61,62]. A united-atom representation was adopted
for the acyl chains of the POPC lipid molecules [63]. The water
molecules were described using the TIP3P model [64,65]. Periodic
boundary conditions were employed for all of the MD simulations
and the electrostatic potential was evaluated using the particle-
mesh Ewald method [66]. The lengths of all bonds containing
hydrogen were constrained with the SHAKE/RATTLE algo-
rithm [67]. The system was maintained at a temperature of 300 K
and pressure of 1 atm using the Langevin thermostat and barostat
methods as implemented in the MD code NAMD2.8 [68] (Figure
S1). The rRESPA multiple time step method was employed, with a
high frequency timestep of 2.0 fs and a low frequency time step of
4.0 fs.
This computational setup has several limitations. First, the time-
scales achievable by our MD simulation are too short to observe
channel gating. Second, the small size of the lipid bilayer in the
simulation box results in an excessive drug concentration in the
bilayer. The final limitation stems from the use of a oversimplified
POPC lipid bilayer. Bacterial sodium channel function is strongly
lipid dependent [40]. However, NaChBac is functional in
liposomes containing POPC and in mammalian cells, making
POPC a reasonable choice for NaChBac simulations.
Cluster analysis
To identify binding sites, we analyzed equilibrated configura-
tions of the system and seeking regions characterized by high
density of isoflurane. We first computed the center of mass (COM)
of each isoflurane molecule in the MD trajectory frame. We then
performed a cluster analysis on the resulting set of COM positions
using the geometric distance between each pair of positions to
build a proximity matrix. Partitioning of the set (clustering) was
obtained using the Jarvis-Patrick algorithm [27] with a nearest-
neighbor list of 8 and shared-neighbor threshold of 3. We then
ranked the clusters according to their average density. Here, we
treated each COM position as an isotropic Gaussian density of
width 1 A˚, and summed over all the COM positions belonging to
a given cluster. Integration of the density for each cluster was
performed on a 3-dimensional grid with bin dimensions of
0.560.560.5 A˚3. The top three ranked clusters, comprising 15%
of the total number of configurations, are discussed as putative
binding regions.
Free energy calculations
Free energy calculations were performed using the free energy
perturbation (FEP) method. The binding free energies are
calculated using the following scheme: DGbind = DGgas–prot2
(DGsolv+DGrstr). Here, DGbind is the free energy of binding
isoflurane to NaChBac, DGvac-.prot is the free energy of
transferring an isoflurane from the gas phase to the binding site,
DGsolv is the isoflurane solvation free energy, and DGrstr is a
measure of the entropy cost associated with the reduction in
volume from a 1 M solution (V1M) to the volume available at the
binding site (Vrstr), i.e., DGrstr = RT ln(Vrstr/V1M). For all reported
binding energies, V1M is given by the volume associated with the
flat-bottom spherical restraint applied to keep the isoflurane in the
binding site during the interaction decoupling. Calculations were
performed in NAMD 2.8 by varying the coupling parameter in
steps of 0.025 at the ends and 0.05 in the middle.
This approach has been successfully applied to binding of
anesthetics to proteins including the binding of R- and S-
isoflurane enantiomers to apoferritin [69] as well as the binding
of isoflurane and propofol to the GLIC bacterial ion channel [33].
The estimated binding free energy for isoflurane was assuming
that the only two relevant thermodynamic states are protein-
bound isoflurane aqueous isoflurane. Therefore the water-lipid
partitioning is not considered. However, since the affinity of
isoflurane for a hydrophobic phase is significantly lower than our
estimated affinities (DG of transfer from water to dodecane is
3.0 kcal/mol), we expect the lipid partitioning to have a marginal
effect on the apparent Kd.
Supporting Information
Figure S1 (A) Left: displacement along the bilayer normal of the
centers of mass of the isoflurane molecules as a function of time.
Different colors are used to show the instantaneous positions of
different isoflurane molecules. Right: density profile along the
bilayer normal calculated for the centers of mass of all the
isoflurane molecules averaged over the first 100 ns (black) and the
subsequent 450 ns (red). Note that in the latter the values of the
density outside the bilayer region are negligible. (B) Plot showing
number of isoflurane molecules in aqueous phase over time. Inset
show magnified scale for 100–550 ns, after isoflurane is fully
partitioned. (C) Probability distribution function of the number of
isoflurane molecules computed over the last 100 ns of simulation.
The average number of isoflurane in water over this period is 0.4.
(TIFF)
Figure S2 Root mean square deviation (RMSD) of the
backbone atoms from the initial structure employed in the MD
simulation plotted as a function of time for the flooding simulation.
The RMSD is shown separately for different regions of the
channel: entire channel (black), voltage-sensor domains (blue),
pore domain (red), and selectivity filter (green).
(TIFF)
Movie S1 Isoflurane flooding. The NaChBac pore domain (blue
ribbons) sits in the bilayer (headgroups shown as grey spheres)
while isoflurane (red/green molecules) begins in the aqueous
compartment above and below the bilayer and partitions first into
the bilayer and then into the protein structure. Voltage sensing
domains, water molecules and lipid alkyl tails are not shown in this
movie but are present in the simulation (Figure 1A).
(MPG)
Movie S2 Representative isoflurane trajectory through fenestra-
tion to cavity site. Bottom view of NaChBac structure (grey
ribbons) surrounded by lipid molecules (stick representations).
Binding of Isoflurane to NaChBac
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Isoflurane (blue, space-filling representation) enters from the lipid
phase into the cavity through a fenestration.
(MPG)
Table S1 Proximity of isoflurane to residues within each site.
The table reports the relative frequencies (as a percentage of
frames) of contacts between isoflurane and the residues lining each
binding site (a contact is detected if the distance between any atom
of the isoflurane molecule and any atom of the given residue is
smaller than 5 A˚). Residues are classified as non-interacting (red),
possibly interacting (orange), and likely interacting (green)
depending on the probability of being engaged in a contact.
(DOCX)
Table S2 Dynamics of Isoflurane in binding sites. Diffusion
coefficients and rotational relaxation times of isoflurane computed,
at each binding site, by averaging over a trajectory of
approximately 500 ns. The water self-diffusion coefficient and
the rotational relaxation time for the TIP3P model is reported for
comparison.
(DOCX)
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